I feel strangely confident in this stock. It really is kind of dangerous to feel this way with a biotech, except that I feel like we have the Prurisol insurance policy if something goes wrong with Kevetrin.

My example is MDVN. I got KILLED on MDVN when it was cut in half on poor test results, went from 20 to 10 in no time flat. I had call options and they became worthless in 2 seconds when the news was announced.

However, MDVN then QUINTUPLED in the next couple of years, from that low level. If I had had the stock instead of calls, I could have ridden it out and made a lot of money.

So, we have Prurisol as a back-up, and the autism drug and whatever else is patiently waiting its turn....